Identifikatu
Taldeak
Ikertzaileak
Emaitzak
GUILLERMO
LÓPEZ VIVANCO
Ikertzailea 2022-(e)ra arte
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, España
Hemen zaude
Lankidetzak
Hospital Universitario Nuestra Señora de Candelaria
Hospital Universitario Nuestra Señora de Candelaria -ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2022
Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)
Lung Cancer, Vol. 173, pp. 83-93
2012
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial
The Lancet Oncology, Vol. 13, Núm. 3, pp. 239-246
Kontaktua
Lege-oharra
Laguntza
translate
eu
arrow_drop_down
translate
eu
arrow_drop_down
es
en
fr
de